FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Zyno Medical Recalls Infusion Pumps

[ Price : $8.95]

Zyno Medical recalls certain Z-800 infusion pumps because they were released to customers with incorrect software versions.

Qalitex Warns of Growing FDA-Amazon Enforcement Overlap

[ Price : $8.95]

Qalitex Laboratories issues an alert to dietary supplement and wellness product sellers on Amazon about a growing overlap between ...

AbbVie's Venetoclax Fails to Improve Survival in Trial

[ Price : $8.95]

An AbbVie Phase 3 (VERONA) clinical trial evaluating venetoclax in combination with azacitidine for newly diagnosed higher-risk my...

Incyte Reports Positive Data on Neoplasm Drug

[ Price : $8.95]

Incyte reports the first positive clinical data from studies evaluating a novel, first-in-class targeted monoclonal antibody in pa...

Sumitomo Pharma Gets Fast Track Status for Nuvisertib

[ Price : $8.95]

FDA grants Sumitomo Pharma a fast-track designation for nuvisertib (TP-3654) for treating patients with intermediate or high-risk ...

Keytruda OKd for Head-Neck Cancer Pre/Post-Surgery

[ Price : $8.95]

FDA approves Mercks Keytruda (pembrolizumab) as the first anti‑PD‑1 therapy that can be given both before and after su...

FDA Clinical Hold on Pulmonary Fibrosis Drug

[ Price : $8.95]

FDA places a clinical hold on a Rein Therapeutics Phase 2 (RENEW) trial of LTI-03 due to agency requests for additional non-clinic...

Guide on ANDA Pre-Submission Facility Correspondence

[ Price : $8.95]

FDA posts a final guidance entitled ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submis...

Senators Introduce Bill to Ban DTC Drug Advertising

[ Price : $8.95]

Senators Bernie Sanders (I-VT) and Angus King (I-ME) introduce legislation that would ban direct-to-consumer drug advertising.

Oncologic Panel to Review Multiple Myeloma BLA

[ Price : $8.95]

FDA schedules a 7/17 meeting of its Oncologic Drugs Advisory Committee to review and vote on a GSK BLA for Blenrep (belantamab maf...